-
1.发明公开METHODS AND FLUORINATED COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES 审中-公开方法和氟化合物淀粉样蛋白相关性疾病的治疗
公开(公告)号：EP1828111A2
公开(公告)日：2007-09-05
申请号：EP05850824.3
申请日：2005-11-14
申请人： Neurochem (International) Limited , Kong, Xianqi , Wu, Xinfu , Bouzide, Abderrahim , Valade, Isabelle , Migneault, David , Bellini, Francesco
发明人： KONG, Xiangi , WU, Xinfu , BOUZIDE, Abderrahim , VALADE, Isabelle , MIGNEAULT, David , BELLINI, Francesco
IPC分类号： C07C309/13 , C07C309/14 , C07C313/02 , A61K31/185 , A61P25/28
CPC分类号： C07C229/08 , C07C229/20 , C07C309/14 , C07C309/15 , C07C309/19 , C07C309/24 , C07C313/04 , C07C323/25 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2602/10 , C07C2603/74
摘要： Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease. Also described are methods, compounds, pharmaceutical compositions and kits for detecting, diagnosing, monitoring and treating or preventing amyloid-related disease.
摘要翻译： 方法，化合物，药物组合物和试剂盒中描述用于治疗或预防淀粉样蛋白相关疾病。 如此描述的方法，化合物，药物组合物和试剂盒检测，诊断，监测和治疗或预防淀粉样蛋白相关疾病。
-
2.发明公开
公开(公告)号：EP3402524A1
公开(公告)日：2018-11-21
申请号：EP17738062.3
申请日：2017-01-11
申请人： Klox Technologies Limited , Bellini, Francesco , Salvaggio, Alberto , Palumbo Piccionello, Angela , Spaterna, Andrea , Loupis, Nikolaos , Hébert, Lise , Ohayon, David , Piergallini, Remigio
发明人： BELLINI, Francesco , SALVAGGIO, Alberto , PALUMBO PICCIONELLO, Angela , SPATERNA, Andrea , LOUPIS, Nikolaos , HÉBERT, Lise , OHAYON, David , PIERGALLINI, Remigio
CPC分类号： A61K41/0057
摘要： The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for use in the treatment of skin and soft tissue wounds that have either or both non-resistant and resistant infections.
-
公开(公告)号：EP3463467A1
公开(公告)日：2019-04-10
申请号：EP17801865.1
申请日：2017-05-23
-
公开(公告)号：EP3402523A1
公开(公告)日：2018-11-21
申请号：EP17738060.7
申请日：2017-01-11
申请人： Bellini, Francesco , Klox Technologies Limited , Spaterna, Andrea , Marchegiani, Andrea , Loupis, Nikolaos , Piergallini, Remigio
发明人： BELLINI, Francesco , SPATERNA, Andrea , MARCHEGIANI, Andrea , LOUPIS, Nikolaos , PIERGALLINI, Remigio
CPC分类号： A61K41/00 , A61K9/0014 , A61K9/06 , A61K31/17 , A61K31/352 , A61K31/401 , A61K33/40 , A61K45/06 , A61K2300/00
摘要： The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of pyoderma, deep pyoderma, or antibiotic resistant pyoderma.
-
公开(公告)号：EP3402522A1
公开(公告)日：2018-11-21
申请号：EP17738059.9
申请日：2017-01-11
申请人： Bellini, Francesco , Klox Technologies Limited , Cerquetella, Matteo , Tambella, Adolfo Maria , Spaterna, Andrea , Loupis, Nikolaos , Ohayon, David , Piergallini, Remigio
发明人： BELLINI, Francesco , CERQUETELLA, Matteo , TAMBELLA, Adolfo Maria , SPATERNA, Andrea , LOUPIS, Nikolaos , OHAYON, David , PIERGALLINI, Remigio
CPC分类号： A61K41/00 , A61K9/0046 , A61K9/06 , A61K31/17 , A61K31/352 , A61K33/40 , A61K45/06 , A61K47/32 , A61K2300/00
摘要： The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
-
公开(公告)号：EP3377054A1
公开(公告)日：2018-09-26
申请号：EP16865362.4
申请日：2016-11-18
IPC分类号： A61K31/185 , A23K20/10 , A23K50/40 , A61P25/00 , C07C309/14 , C12Q1/00
CPC分类号： A61K31/185 , A23K20/10 , A23K50/40 , A61K45/06 , A61K2300/00
摘要： The present disclosure generally relates to compounds comprising homotaurine that may be used in improving the general mental condition and/or general brain function of a non- human animal, and for the prophylaxis of chronic, aging-related mental deterioration in non- human animals. In addition, the present disclosure generally relates to compositions comprising homotaurine that may be used in determining whether a candidate veterinary compound and/or a candidate formulation can improve general mental condition and/or general brain function of animals and for the prophylaxis of chronic, aging-related mental deterioration in non-human animals.
-
7.发明公开THERAPEUTIC FORMULATIONS FOR THE TREATMENT OF BETA-AMYLOID RELATED DISEASES 审中-公开治疗制剂·对于β-淀粉样蛋白相关疾病的治疗
公开(公告)号：EP1841460A2
公开(公告)日：2007-10-10
申请号：EP05858504.3
申请日：2005-06-17
IPC分类号： A61K45/06
CPC分类号： A61K45/06 , A61K31/185 , A61K31/27 , A61K31/445 , A61K2300/00
摘要： This invention relates to methods and pharmaceutical compositions for treating amyloid-β related diseases, including Alzheimer’s disease. The invention, for example, includes a method of concomitant therapeutic treatment of a subject, comprising administering an effective amount of a first agent and a second agent, wherein said first agent treats an amyloid-β disease, neurodegeneration, or cellular toxicity; and said second agent is a therapeutic drug or nutritive supplement.
-
8.发明公开THERAPEUTIC FORMULATIONS FOR THE TREATMENT OF BETA-AMYLOID RELATED DISEASES 审中-公开治疗组合物FORβ-淀粉样蛋白相关疾病的治疗
公开(公告)号：EP1581203A1
公开(公告)日：2005-10-05
申请号：EP03788737.9
申请日：2003-12-24
IPC分类号： A61K31/185 , A61K38/00 , A61P25/28
CPC分类号： A61K31/185 , A61K31/445 , A61K38/07 , A61K38/08 , A61K38/10 , A61K38/1709 , A61K45/06 , A61K2300/00
摘要： The method is used for preventing or treating an amyloid-β related disease in a subject. The method comprises administering to a subject in need thereof an effective amount of a first agent that prevents or treats amyloid-β related disease, and a second agent that is (i) a peptide or peptidomimetic that modulates amyloid-β fibril formulation or induces a prophylactic or therapeutic immune response against amyloid-β fibril formulation, or (ii) an immune system modulator that prevents or inhibits amyloid-β fibril formulation.
-
9.发明公开THERAPEUTIC FORMULATIONS FOR THE TREATMENT OF BETA-AMYLOID RELATED DISEASES 审中-公开治疗组合物用于β淀粉样蛋白相关疾病的治疗
公开(公告)号：EP1585520A1
公开(公告)日：2005-10-19
申请号：EP03767368.8
申请日：2003-12-24
IPC分类号： A61K31/445 , A61K31/185 , A61P25/28
CPC分类号： A61K31/185 , A61K31/445 , A61K38/07 , A61K38/08 , A61K38/10 , A61K38/1709 , A61K45/06 , A61K2300/00
摘要： This invention relates to methods and pharmaceutical compositions for treating amyloid-ß related diseases, including Alzheimer's disease. The invention, for example, includes a method of concomitant therapeutic treatment of a subject, comprising administering an effective amount of a first agent and a second agent, wherein said first agent treats an amyloid-ß disease, neurodegeneration, or cellular toxicity; and said second agent is a therapeutic drug or nutritive supplement.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.023 秒)
